153 filings
10-K
2023 FY
LTRN
Lantern Pharma Inc
Annual report
18 Mar 24
4:05pm
8-K
LTRN
Lantern Pharma Inc
18 Mar 24
Lantern Pharma Reports Fourth Quarter & Fiscal Year 2023 Financial Results and Business Highlights
4:05pm
SC 13D/A
Bios Equity Partners, LP
1 Mar 24
Lantern Pharma / Bios Equity Partners ownership change
4:10pm
4
BIOS Capital Management, LP
29 Feb 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
9:54pm
4
Cavu Advisors, LLC
29 Feb 24
Lantern Pharma / Leslie W. Kreis ownership change
9:54pm
144
33f7oytj8m 6wjk
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
jzk4f
28 Feb 24
Notice of proposed sale of securities
9:41pm
144
5wnl4y1
28 Feb 24
Notice of proposed sale of securities
9:40pm
SC 13G/A
33nlvte bce6e2
14 Feb 24
Lantern Pharma / ProPhase Labs ownership change
4:05pm
4
o2g1b5q3rj3vcobnaf
19 Jan 24
Lantern Pharma / Aaron G.L. Fletcher ownership change
4:31pm
4
hw8kxs4v
19 Jan 24
Lantern Pharma / Leslie W. Kreis ownership change
4:30pm
8-K
f7fv6xn
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
SC 13D/A
c2461im2lc
1 Dec 23
Lantern Pharma / Bios Equity Partners ownership change
6:02am
4
z3nvm6m yi
1 Dec 23
Lantern Pharma / Aaron G.L. Fletcher ownership change
6:01am
4
6uo a1swidur
1 Dec 23
Lantern Pharma / Leslie W. Kreis ownership change
6:00am
8-K
kttwaqkjyqmal065
24 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
103jmck lxbq
8 Nov 23
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
girne3wjzg6s62
20 Oct 23
Other Events
5:25pm